Financials
- Market Capitalization 12.51 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3 449
市销率
5.56
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 803 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 65.29 USD | -0.49% | -3.03% | +5.19% | +13.47% | 12.64 B USD | ||
| 806 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 543.69 USD | +0.89% | +3.94% | +0.39% | +28.35% | 12.56 B USD | ||
| 824 | HALO Halozyme Therapeutics, Inc. - Common Stock | 106.92 USD | -0.13% | +0.68% | +28.70% | +60.06% | 12.14 B USD | ||
| 852 | SMMT Summit Therapeutics Inc. - Common Stock | 14.33 USD | +0.70% | +12.83% | +13.64% | -27.84% | 11.43 B USD |